protein

Recombinant Canine Tie-2 His-tag Protein, CF

10781-T2-050

50 ug

491 USD

10781-T2-050

Recombinant Canine Tie-2 His-tag Protein, CF

50 ug

The Recombinant Canine Tie-2 His-tag Protein, CF from R&D Systems is derived from NS0. The Recombinant Canine Tie-2 His-tag Protein, CF has been validated for the following applications: Bioactivity.

Tie-2

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose.

Unconjugated

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.

Canine

95-105 kDa, under reducing conditions

82 kDa

Measured by its binding ability in a functional ELISA. When Recombinant Canine Tie-2 His-tag (Catalog # 10781-T2) is immobilized at 0.5 ╡g/mL (100 ╡L/well), Recombinant Human Angiopoietin-2 (Catalog # 623-AN ) binds with an ED50 of 0.40-3.60 ng/mL

<0.10 EU per 1 ╡g of the protein by the LAL method.

XP_005626754.1

Bioactivity

Mouse myeloma cell line, NS0-derived canine Tie-2 protein Ala23-Lys746, with a C-terminal 6-His tag

NS0

491 USD

angiopoietin-1 receptor, CD202B, CD202b antigen, EC 2.7.10, EC 2.7.10.1, hTIE2, p140 TEK, soluble TIE2 variant 1, soluble TIE2 variant 2, TEK, TEK tyrosine kinase, endothelial, Tie2, TIE-2, TIE2CD202b, Tunica interna endothelial cell kinase, Tyrosine-protein kinase receptor TEK, Tyrosine-protein kinase receptor TIE-2, venous malformations, multiple cutaneous and mucosal, VMCM, VMCM1

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.